FilingSEC EDGAR8-K
Ainos Enters Global Exclusive License Agreement with BioPhoenix for VELDONA Platform
· SEC accepted
StageAgreement Executed
Filing content
Ainos has entered into a global exclusive license agreement with BioPhoenix for its VELDONA platform, securing an initial $600,000 fee and up to $10 million in potential future payments.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…